investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer

Peter Kent Jackson

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Peter Kent Jackson

Stanford University

Stanford, United States

Related projects

Xifeng Wu

Epigenetic miRNA, SNP Signatures, and their Functions in Lung Cancer Outcomes

Trachea, bronchus and lung

Roger D Kamm

Microfluidic 3D Assays for Metastatic Cancer

Trachea, bronchus and lung

Bingliang Fang

Overcoming Resistance to Anti-EGFR Therapy by Drug Repurposing

Trachea, bronchus and lung

Kim O'Neill

Cancer Immunology Research at Brigham Young University

Trachea, bronchus and lung

Nathanael Schiander Gray

Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors

Trachea, bronchus and lung

Jeffrey Mackeigan

Computational Model of Autophagy-Mediated Survival in Chemoresistant Lung Cancer

Trachea, bronchus and lung

Pathology

Michele Carbone

Germline BAP1 Mutations and Malignant Mesothelioma: Mechanisms and Early Detection

Trachea, bronchus and lung

Pathology

Martin Mcmahon

Studying the Initiation, Progression and Therapy of Lung Cancer in Mouse Models

Trachea, bronchus and lung

Pathology

Giovanna Tosato

A Role for KSHV in the Pathogenesis of Malignancies

Trachea, bronchus and lung

Pathology Hematology and hematologic malignancies